Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
17
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Xu Stella | Director | 5 | $0 | $0 | 2018-06-22 |
| Rizvi Naiyer | Director | 3 | $0 | $0 | 2018-06-22 |
| Leveque Joseph | Chief Medical Officer | 1 | $0 | $0 | 2018-06-22 |
| KPCB XIV Associates, LLC | 10% Owner | 1 | $0 | $0 | 2018-06-22 |
| OrbiMed Capital GP IV LLC | 10% Owner | 2 | $0 | $0 | 2018-06-22 |
| Cui Xiangmin | Director | 5 | $0 | $0 | 2018-06-22 |
| Legault Pierre | Director | 3 | $0 | $0 | 2018-06-22 |
| GORDON CARL L | Director, 10% Owner | 13 | $0 | $0 | 2018-06-22 |
| VAN VLASSELAER PETER | President and CEO | 5 | $0 | $0 | 2018-06-22 |
| CROSS HERB | Chief Financial Officer | 1 | $0 | $0 | 2018-06-22 |
| SEIDENBERG BETH C | Director, 10% Owner | 10 | $0 | $0 | 2018-06-22 |
| GV 2014, L.P. | 10% Owner | 2 | $0 | $0 | 2018-01-30 |
| GV 2016 GP, L.P. | 10% Owner | 2 | $0 | $0 | 2018-01-30 |
| SEQUOIA CAPITAL CHINA VENTURE FUND VI, L.P. | 10% Owner | 2 | $0 | $0 | 2018-01-30 |
| DAG Ventures Management V, LLC | Other | 20 | $0 | $0 | 2018-01-30 |
| Kleiner Perkins Caufield & Byers XIV, LLC | 10% Owner | 7 | $0 | $0 | 2018-01-30 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 9 | $0 | $0 | 2018-01-30 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| SEIDENBERG BETH C | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| Cui Xiangmin | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| CROSS HERB | Chief Financial Officer | D To issuer deriv | 2018-06-22 | 2018-06-22 | 240,658 | $43.03 | $10.36M | 0 | SEC↗ |
| Rizvi Naiyer | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| Rizvi Naiyer | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 19,146 | $43.27 | $828.4K | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 55,765 | $43.27 | $2.41M | 0 | SEC↗ |
| Legault Pierre | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| VAN VLASSELAER PETER | President and CEO | D To issuer deriv | 2018-06-22 | 2018-06-22 | 190,641 | $48.68 | $9.28M | 0 | SEC↗ |
| VAN VLASSELAER PETER | President and CEO | D To issuer deriv | 2018-06-22 | 2018-06-22 | 398,206 | $46.70 | $18.60M | 0 | SEC↗ |
| VAN VLASSELAER PETER | President and CEO | D To issuer deriv | 2018-06-22 | 2018-06-22 | 216,168 | $43.03 | $9.30M | 0 | SEC↗ |
| VAN VLASSELAER PETER | President and CEO | D To issuer deriv | 2018-06-22 | 2018-06-22 | 220,513 | $48.68 | $10.73M | 0 | SEC↗ |
| Leveque Joseph | Chief Medical Officer | D To issuer deriv | 2018-06-22 | 2018-06-22 | 288,789 | $43.03 | $12.43M | 0 | SEC↗ |
| Xu Stella | Director | D To issuer deriv | 2018-06-22 | 2018-06-22 | 18,000 | $10.03 | $180.5K | 0 | SEC↗ |
| GORDON CARL L | Director | U Tender | 2018-06-22 | 2018-06-22 | 409,547 | $50.00 | $20.48M | 0 | SEC↗ |
| GORDON CARL L | Director | U Tender | 2018-06-22 | 2018-06-22 | 3,709,356 | $50.00 | $185.47M | 0 | SEC↗ |
| SEIDENBERG BETH C | Director | U Tender | 2018-06-22 | 2018-06-22 | 4,266,683 | $50.00 | $213.33M | 0 | SEC↗ |
| Cui Xiangmin | Director | U Tender | 2018-06-22 | 2018-06-22 | 1,214,700 | $50.00 | $60.73M | 0 | SEC↗ |
| KPCB XIV Associates, LLC | 10% Owner | U Tender | 2018-06-22 | 2018-06-22 | 4,266,683 | $50.00 | $213.33M | 0 | SEC↗ |
| OrbiMed Capital GP IV LLC | 10% Owner | U Tender | 2018-06-22 | 2018-06-22 | 3,709,356 | $50.00 | $185.47M | 3,709,356 | SEC↗ |
| OrbiMed Capital GP IV LLC | 10% Owner | U Tender | 2018-06-22 | 2018-06-22 | 409,547 | $50.00 | $20.48M | 409,547 | SEC↗ |
| VAN VLASSELAER PETER | President and CEO | U Tender | 2018-06-22 | 2018-06-22 | 809,865 | $50.00 | $40.49M | 0 | SEC↗ |
| Xu Stella | Director | U Tender | 2018-06-22 | 2018-06-22 | 404,900 | $50.00 | $20.25M | 0 | SEC↗ |
| Cui Xiangmin | Director | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Rizvi Naiyer | Director | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Legault Pierre | Director | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| Xu Stella | Director | A Award deriv | 2018-03-26 | 2018-03-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GV 2016 GP, L.P. | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 607,350 | — | $0 | 0 | SEC↗ |
| Kleiner Perkins Caufield & Bye | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 403,097 | — | $0 | 0 | SEC↗ |
| Kleiner Perkins Caufield & Bye | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 673,173 | — | $0 | 0 | SEC↗ |
| Kleiner Perkins Caufield & Bye | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,212,494 | — | $0 | 0 | SEC↗ |
| Kleiner Perkins Caufield & Bye | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,296,248 | — | $0 | 0 | SEC↗ |
| Kleiner Perkins Caufield & Bye | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 355,429 | — | $0 | 0 | SEC↗ |
| Kleiner Perkins Caufield & Bye | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 326,242 | — | $0 | 0 | SEC↗ |
| Cui Xiangmin | Director | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,214,700 | — | $0 | 0 | SEC↗ |
| GV 2014, L.P. | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 607,350 | — | $0 | 0 | SEC↗ |
| Xu Stella | Director | C Conversion deriv | 2018-01-30 | 2018-01-30 | 404,900 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 326,242 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 403,097 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 673,173 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,212,494 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,296,248 | — | $0 | 0 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 355,429 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 283,627 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 415,869 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,226,156 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,783,704 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 31,315 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 45,961 | — | $0 | 0 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 332,271 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,783,704 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,226,156 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 415,869 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 283,627 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 332,271 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 45,961 | — | $0 | 0 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion deriv | 2018-01-30 | 2018-01-30 | 31,315 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 200,786 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,772 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 728,080 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 2,580 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 1,059,148 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 446 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 183,351 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 226,543 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 551 | — | $0 | 0 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion deriv | 2018-01-30 | 2018-01-30 | 489 | — | $0 | 0 | SEC↗ |
| SEQUOIA CAPITAL CHINA VENTURE | 10% Owner | C Conversion deriv | 2018-01-30 | 2018-02-01 | 809,800 | — | $0 | 0 | SEC↗ |
| GV 2016 GP, L.P. | 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 607,350 | — | $0 | 607,350 | SEC↗ |
| Kleiner Perkins Caufield & Bye | 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 4,266,683 | — | $0 | 4,266,683 | SEC↗ |
| Cui Xiangmin | Director | C Conversion | 2018-01-30 | 2018-01-30 | 1,214,700 | — | $0 | 1,214,700 | SEC↗ |
| GV 2014, L.P. | 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 607,350 | — | $0 | 607,350 | SEC↗ |
| Xu Stella | Director | C Conversion | 2018-01-30 | 2018-01-30 | 404,900 | — | $0 | 404,900 | SEC↗ |
| SEIDENBERG BETH C | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 4,266,683 | — | $0 | 4,266,683 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 3,709,356 | — | $0 | 3,709,356 | SEC↗ |
| GORDON CARL L | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 409,547 | — | $0 | 409,547 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 409,547 | — | $0 | 409,547 | SEC↗ |
| ORBIMED ADVISORS LLC | Director, 10% Owner | C Conversion | 2018-01-30 | 2018-01-30 | 3,709,356 | — | $0 | 3,709,356 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 1,059,148 | — | $0 | 1,059,148 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 2,580 | — | $0 | 2,580 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 728,080 | — | $0 | 1,787,228 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 446 | — | $0 | 5,838 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 183,351 | — | $0 | 2,397,908 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 551 | — | $0 | 5,392 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 226,543 | — | $0 | 2,214,557 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 489 | — | $0 | 4,841 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 200,786 | — | $0 | 1,988,014 | SEC↗ |
| DAG Ventures Management V, LLC | Other | C Conversion | 2018-01-30 | 2018-01-30 | 1,772 | — | $0 | 4,352 | SEC↗ |
| SEQUOIA CAPITAL CHINA VENTURE | 10% Owner | C Conversion | 2018-01-30 | 2018-02-01 | 809,800 | — | $0 | 809,800 | SEC↗ |